Hoba Therapeutics ApS: Financial statements 2022
CVR: 38231170
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,181,695 and a net result of DKK -10,898,671 compared with DKK -1,944,679 the year before. Equity in the 2022 report amounted to DKK -18,974,916. The company had 3 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -7,181,695
- Profit/Loss
- DKK -10,898,671
- Equity
- DKK -18,974,916
- Total Assets
- DKK 19,646,302
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -7.2M | -10.9M | -19M | 3 |
| 2021 | - | 1.4M | -1.9M | 8.2M | 3 |
| 2020 | - | 839K | -1.6M | 10.1M | 2 |
| 2019 | - | 296K | -1.1M | 11.7M | - |
| 2018 | - | 485K | -892K | 8.9M | - |
Official annual report
Keep an eye on Hoba Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 28, 2022, EY Godkendt Revisionspartnerselskab has been appointed auditor of Hoba Therapeutics ApS.
As of June 28, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Hoba Therapeutics ApS.
As of June 28, 2022, Lene Gerlach has joined the board of directors of Hoba Therapeutics ApS.
As of June 28, 2022, Thor Jespersen has left the board of directors of Hoba Therapeutics ApS.
About Hoba Therapeutics ApS
Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.
